Exchange: NASDAQ·Updated 05:19 AM EDT
PRME logo

PRME Prime Medicine Inc

$3.77
$0.06
(1.62%)
Pre-Market
Prev Close $3.71
Reported EarningsAug 6
Mkt Cap$665.65M
Vol12,259.00

About PRME

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
36

Bearish Sentiment

How do you feel about PRME?

Advertisement|Remove ads.